Polyethylene Glycol 3350, Powder For Solution
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Glenmark Therapeutics Inc., Usa for the product Polyethylene Glycol 3350 (NDC 72657-196). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding polyethylene glycol 3350, powder for solution, active ingredient (in each dose) (can only), purpose, active ingredient (in each dose) (packet only), use, allergy alert:, otc - do not use, ask a doctor before use if you have, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Polyethylene Glycol 3350, 17 g (cap filled to line)
Osmotic Laxative
Osmotic Laxative
Polyethylene Glycol 3350, 17 g
Do not use if you are allergic to polyethylene glycol
Do not use if you have kidney disease, except under the advice and supervision of a doctor
Ask a doctor or pharmacist before use if you are taking a prescription drug
When using this product you may have loose, watery, more frequent stools
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
none
Call weekdays 9 AM to 5 PM at 1 (888) 721-7115
Polyethylene Glycol 3350 powder for solution increases frequency of bowel movements and softens the stool.
Distributed by
Glenmark Therapeutics Inc., USA
Mahwah, NJ 07430
NDC 72657-196-16Polyethylene Glycol 3350
Powder for Solution
Osmotic Laxative
45 ONCE-DAILY DOSES
NET WT 26.9 OZ (765 g) EACH
45s Label front
* Please review the disclaimer below.